Compare BioNano Genomics Inc (BNGO) vs Levi Strauss & Co. (LEVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Levi Strauss & Co. — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Levi Strauss & Co. trades at $22.73 (market cap $8.75B). The key difference: Levi Strauss & Co. is far larger — about 640.6× BioNano Genomics Inc's market cap, and Levi Strauss & Co. pays a 2.81% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | LEVI | |
|---|---|---|
Market Cap | $13.66M | $8.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $25.53 |
52-Week Low | $1.06 | $17.92 |
Enterprise Value | $16.26M | $10.07B |
Dividend Yield | — | 2.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →
